ECMO for cardiac arrest: does it help patients survive a year?

NCT ID NCT06397417

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study looks at 840 people in Paris whose hearts stopped and didn't restart with standard CPR. They received a special life-support machine called ECMO to keep blood flowing. Researchers will track how many survive for one year and how well their brains recover. The goal is to see if this emergency technique works in real life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that ECMO is an effective real-world treatment for people whose hearts don't restart after a cardiac arrest, potentially saving more lives.
What could go wrong: This is an observational study, not a controlled trial, so it can't prove ECMO is better than other treatments. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION OUT-OF-HOSPITAL CARDIAC ARREST

Contacts and locations

Locations

Hôpital Necker-Enfants Malades
RECRUITING

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.